Zymeworks, Inc. (ZYME)
23.29
0.00 (0.00%)
USD |
NASDAQ |
Mar 02, 16:00
23.69
+0.40
(+1.72%)
After-Hours: 20:00
Zymeworks EPS Diluted (Quarterly) : -0.2587 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Vertex Pharmaceuticals, Inc. | 4.651 |
| Krystal Biotech, Inc. | 1.699 |
| Scholar Rock Holding Corp. | -0.8988 |
| Stoke Therapeutics, Inc. | -0.6543 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.60M |
| Revenue (Quarterly) | 27.61M |
| Total Expenses (Quarterly) | 47.22M |
| Enterprise Value | 1.523B |
| Gross Profit Margin (Quarterly) | 90.64% |
| Profit Margin (Quarterly) | -70.99% |
| Earnings Yield | -3.64% |
| Normalized Earnings Yield | -3.625 |